Alisa Lask
CIK 1767593 · last filed 2025-01-03
Alisa Lask is a corporate insider who has filed 13 SEC Form 4 insider transactions across 2 companies since 2019. The most recent filing, for NEPH, was dated Jan 3, 2025. Across all open-market trades the lifetime net is +$1.6K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $162.4K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$162.4K
2
13
$1.6K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NEPH | Director | 48,629 | $3.34 | $162.4K | $1.6K | 8 | 2025-01-03 |
| RVL Pharmaceuticals plc (RVLP) Delisted | Director | 112,557 | $0.03 | $3.2K | $0 | 3 | 2023-08-14 |
Recent Filings
13 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-01-03 | NEPH | Grant (A) | — | $0 | EDGAR |
| 2024-05-16 | NEPH | Grant (A) | — | $0 | EDGAR |
| 2023-12-15 | NEPH | Grant (A) | +9,291 | $0 | EDGAR |
| 2023-08-14 | RVL Pharmaceuticals plc (RVLP) Delisted | Tax (F) | −12,000 | -$5.9K | EDGAR |
| 2023-07-11 | RVL Pharmaceuticals plc (RVLP) Delisted | Grant (A) | +40,000 | $0 | EDGAR |
| 2023-01-09 | NEPH | Grant (A) | +27,613 | $0 | EDGAR |
| 2022-08-12 | RVL Pharmaceuticals plc (RVLP) Delisted | Grant (A) | +75,000 | $0 | EDGAR |
| 2021-12-16 | NEPH | Grant (A) | +4,582 | $0 | EDGAR |
| 2021-01-08 | NEPH | Grant (A) | +3,666 | $0 | EDGAR |
| 2019-12-18 | NEPH | Grant (A) | +3,227 | $0 | EDGAR |